Prostate Cancer Trial, Recruiting (NCT05767307)

Prostate Cancer Trial, Recruiting NCT05767307 Sponsor: Aarhus University Hospital Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05767307 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who can understand spoken and written Danish
People who have been referred for an MRI scan (either a full multi-parametric or a bi-parametric type) due to a suspicion of prostate cancer at one of three specific hospitals: Aarhus University Hospital (AUH), Odense University Hospital (OUH), or Herlev-Gentofte Hospital (HGH)

Who may not be able to join:

People who have previously been diagnosed with prostate cancer or other cancers affecting the urinary or reproductive organs
People who have a medical reason that prevents them from having an MRI scan (such as certain metal implants or other MRI-related safety concerns)
People who have previously undergone gender reassignment treatment
People whose PSA blood test result is higher than 20 μg/l (a specific measurement of a protein linked to prostate health — the trial site can explain what this means for a particular case)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4578452616

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05767307

Sponsor: Aarhus University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +4578452616

More information: https://clinicaltrials.gov/study/NCT05767307

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who can understand spoken and written Danish
People who have been referred for an MRI scan (either a full multi-parametric or a bi-parametric type) due to a suspicion of prostate cancer at one of three specific hospitals: Aarhus University Hospital (AUH), Odense University Hospital (OUH), or Herlev-Gentofte Hospital (HGH)

Who may not be able to join:

People who have previously been diagnosed with prostate cancer or other cancers affecting the urinary or reproductive organs
People who have a medical reason that prevents them from having an MRI scan (such as certain metal implants or other MRI-related safety concerns)
People who have previously undergone gender reassignment treatment
People whose PSA blood test result is higher than 20 μg/l (a specific measurement of a protein linked to prostate health — the trial site can explain what this means for a particular case)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Aarhus University Hospital

Registry

ClinicalTrials.gov

Start date

1 August 2022

Est. completion

31 December 2025

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Number of MRI scans used to detect clinically significant PCs.; Clinically significant PC diagnoses compared to benign biopsies.; Clinically significant PC diagnoses compared to clinically insignificant PC diagnoses.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov